Combined with chemotherapy and immunotherapy, AstraZeneca’s Calquence reduced the risk of disease progression or death by 27% compared to placebo and chemoimmunotherapy in first-line mantle …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Periodontal disease is a growing public health issue in the United States as the nation’s population ages, yet it’s underdiagnosed and undertreated.
Study to test effectiveness of Instructional System Designs (ISD) model for Intranasal SPC-15 Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused
The FDA has fast-tracked Invectys’ CAR-T therapy in renal cell carcinoma. Credit: Nemes Laszlo via Shutterstock. The US Food and Drug Administration (FDA) has granted